Cogstate to Present at the NORD Rare Diseases and Orphan Products Breakthrough Summit
Cogstate today announced a presentation entitled, “Methodology for Development of Indication-Specific Outcome Measures in Rare Disease Trials: An Innovative Research Approach” will be delivered at the National Organization for Rare Diseases (NORD) Rare Disease Summit in Washington, D.C.
October 11, 2018
Cogstate Establishes Rare Disease and Pediatric Center of Excellence
Cogstate today announced the establishment of a Rare Disease and Pediatric Center of Excellence to lead all activities related to the selection and administration of cognitive and behavioral outcome measures in rare disease and pediatric clinical trials.
April 5, 2018
